REGISTERED
on 14 Mar 2023
Last Applicant/ Owned by
801 California Street
Mountain View
CA
94022
Serial Number
88020634 filed on 29th Jun 2018
Registration Number
7000700 registered on 14th Mar 2023
Correspondent Address
Connie L. Ellerbach
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
EARLI
Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic prepara Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases
First Use Date in General
18th Jan 2023
First Use Date in Commerce
18th Jan 2023
Class [001]
Chemical Products
Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use
First Use Date in General
18th Jan 2023
First Use Date in Commerce
18th Jan 2023
Mark Details
Serial Number
No 88020634
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 34601-00070
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 14th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 10th Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Feb 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 02th Feb 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 31st Jan 2023 | TEAS STATEMENT OF USE RECEIVED |
| 31st Jan 2023 | USE AMENDMENT FILED |
| 18th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Jan 2023 | SOU EXTENSION 5 GRANTED |
| 04th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |